MedPath

Diversity in blood flow control to the brai

Not Applicable
Completed
Conditions
Acute and chronic stroke
Circulatory System
Stroke, not specified as haemorrhage or infarction
Registration Number
ISRCTN17736632
Lead Sponsor
niversity of Leicester (UK)
Brief Summary

1. 2016 white paper in https://doi.org/10.1177/0271678X15626425 (added 30/10/2020) 2. 2016 healthy volunteer results in https://doi.org/10.1088/0967-3334/37/9/1485 (added 30/10/2020) 3. 2016 results in https://doi.org/10.1088/0967-3334/37/5/661 (added 30/10/2020) 4. 2017 results in https://doi.org/10.1007/s00421-017-3707-9 (added 30/10/2020) 5. 2018 results in https://doi.org/10.1159/000487514 (added 30/10/2020) 6. 2018 results in https://doi.org/10.14814/phy2.13603 (added 30/10/2020) 7. 2019 results in https://doi.org/10.1088/1361-6579/ab39d3 (added 30/10/2020) 8. 2019 results in https://doi.org/10.1007/s11517-019-02064-0 (added 30/10/2020) 9. 2020 results in https://doi.org/10.1088/1361-6579/ab7ddf (added 30/10/2020) 10. 2020 results in https://doi.org/10.1038/s41598-020-67404-9 (added 30/10/2020) 11. 2020 results in https://doi.org/10.1088/1361-6579/aba67e (added 30/10/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Participant (or relative of the stroke patient) is willing and able to give informed consent (assent) for participation in the study
2. Male or female, aged 18 years or above
3. Able (in the investigator's opinion) and willing to comply with all study requirements
4. Willing to allow his or her General Practitioner to be notified of participation in the study

Stroke patient-specific inclusion criteria:
1. Clinical diagnosis of stroke within 24 hours of onset (for patients waking with a stroke, time of onset will be taken to be the time when the patient was last asymptomatic)

Exclusion Criteria

Co-morbidity with life expectancy less than 3 months

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath